Off-market insider buying at Optimi Health (C:OPTI)

John James Wilson, a Director, acquired 1,000,000 Common Shares on an indirect ownership basis for registered holder Catcher Investments Limited at a price of $0.300 through a prospectus or prospectus exempt offering on February 28th, 2024. The insider also acquired 500,000 Warrants with an exercise price of $0.400 for two years. This represents a $300,000 investment into the company's shares and an account share holdings change of 18.9%.

One other insider also participated in a smaller amount.

Optimi Health is in the Miscellaneous Specialty Retailers Sub Industry Group under the Consumer Cyclicals Sector.

Optimi Health Corp. is an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances, such as 3,4-Methylenedioxymethamphetamine (MDMA), natural Manufacturing Practices (GMP)-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets. The Company produces scalable psychedelic formulations for transformational human experiences. Its products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia. It is a supplier of drug and nutraceutical products. The Company works with customers, health food distributors, and drug developers, and patients regulated by Health Canada.